STTK Shattuck Labs, Inc. - Common Stock
STTK 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
STTK 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
STTK 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 5 31.2%
- 매수 10 62.5%
- 보유 1 6.2%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
8 명의 애널리스트 · 2026-08-14실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $-0.13 | $-0.14 | 0.01% |
| 2025년 12월 31일 | $-0.12 | $-0.14 | 0.02% |
| 2025년 9월 30일 | $-0.14 | $-0.15 | 0.01% |
| 2025년 6월 30일 | $-0.24 | $-0.25 | 0.01% |
| 2025년 3월 31일 | $-0.27 | $-0.29 | 0.02% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| MNPR | — | — | — | — | — | — |
| CTMX | $725M | — | -44.8% | -22.8% | -15.9% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
| NGNE | $319M | -4.9 | — | — | -33.6% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $6M | $2M | $652.0K | $30M | $10M | $10M | |
| R&D Expense | $35M | $67M | $74M | $83M | $57M | $37M | $29M | |
| SG&A Expense | $17M | $19M | $19M | $21M | $19M | $9M | $6M | |
| Operating Expenses | $53M | $86M | $94M | $104M | $75M | $47M | $35M | |
| Operating Income | $-52M | $-81M | $-92M | $-103M | $-45M | $-37M | $-25M | |
| Interest Income | $3M | $5M | $5M | $2M | $625.0K | $549.0K | $1M | |
| Other Non-op | $-4.0K | $-17.0K | $-10.0K | $-208.0K | $-330.0K | $-221.0K | $-99.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-49M | $-75M | $-87M | $-102M | $-45M | $-37M | $-24M | |
| EPS (Basic) | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 | $-2.36 | · | |
| EPS (Diluted) | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 | $-2.36 | · | |
| Shares (Basic) | 69,584,937 | 50,758,290 | 42,600,190 | 42,378,895 | 42,032,384 | 15,506,067 | · | |
| Shares (Diluted) | 69,584,937 | 50,758,290 | 42,600,190 | 42,378,895 | 42,032,384 | 15,506,067 | · | |
| EBITDA | $-48M | · | $-88M | $-100M | $-44M | $-36M | · |
대차대조표 19
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $57M | $126M | $47M | $92M | $158M | $7M | |
| Prepaid Expense | $4M | $6M | $13M | $23M | $19M | $10M | $3M | |
| Current Assets | $82M | $79M | $143M | $185M | $288M | $346M | $42M | |
| PP&E (Net) | $6M | $10M | $14M | $18M | $10M | $3M | $2M | |
| PP&E (Gross) | $23M | $23M | $23M | $23M | $13M | $4M | $3M | |
| Accum. Depreciation | $17M | $13M | $10M | $6M | $3M | $1M | $862.0K | |
| Other Non-current Assets | $1M | $2M | $3M | $3M | $381.0K | $349.0K | $90.0K | |
| Total Assets | $91M | $91M | $160M | $205M | $299M | $349M | $45M | |
| Accounts Payable | $2M | $2M | $2M | $7M | $10M | $2M | $3M | |
| Current Liabilities | $7M | $9M | $11M | $25M | $25M | $17M | $20M | |
| Capital Leases | $2M | $3M | $3M | $4M | $0 | · | · | |
| Total Liabilities | $9M | $11M | $15M | $29M | $27M | $39M | $30M | |
| Common Stock | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $1.0K | |
| Paid-in Capital | $513M | $461M | $451M | $396M | $389M | $382M | $887.0K | |
| Retained Earnings | $-431M | $-382M | $-306M | $-219M | $-117M | $-72M | $-35M | |
| AOCI | $6.0K | $2.0K | $4.0K | $-877.0K | $-560.0K | $-63.0K | $54.0K | |
| Stockholders' Equity | $82M | $80M | $145M | $176M | $272M | $310M | $-35M | |
| Liabilities + Equity | $91M | $91M | $160M | $205M | $299M | $349M | $45M | |
| Shares Outstanding | 63,279,843 | 47,714,708 | 47,260,108 | 42,390,586 | 42,338,898 | 41,767,431 | 7,600,877 |
현금 흐름 11
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $3M | $1M | $600.0K | $500.0K | |
| Stock-based Comp | $7M | $10M | $7M | $6M | $5M | $1M | $461.0K | |
| Other Non-cash | $-2M | · | $-5M | $-2M | $-19M | $1M | · | |
| Operating Cash Flow | $-40M | $-61M | $-81M | $-94M | $-57M | $-34M | $-21M | |
| CapEx | $71.0K | $59.0K | $407.0K | $12M | $8M | $727.0K | $470.0K | |
| Investing Cash Flow | $-8M | $-9M | $111M | $49M | $-10M | $-146M | $-4M | |
| Stock Issued | $44M | · | $48M | $0 | · | · | · | |
| Net Stock Activity | $44M | · | $48M | · | · | · | · | |
| Financing Cash Flow | $45M | $787.0K | $49M | $171.0K | $2M | $331M | $-64.0K | |
| Net Change in Cash | $-3M | $-68M | $78M | $-45M | $-66M | $151M | $-25M | |
| Free Cash Flow | $-40M | · | $-82M | $-106M | $-65M | $-34M | · |
수익성 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5150.8% | · | -5549.6% | -15848.0% | -150.8% | -371.8% | · | |
| Net Margin | -4880.9% | · | -5268.4% | -15635.7% | -149.8% | -368.5% | · | |
| EBITDA Margin | -4780.8% | · | -5308.2% | -15372.6% | -146.2% | -365.7% | · | |
| ROA | -53.6% | · | -47.9% | -40.5% | -13.9% | -18.6% | · | |
| ROE | -70.0% | · | -67.8% | -54.3% | -16.9% | -29.1% | · |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.7 | · | 12.5 | 7.4 | 11.7 | 20.5 | · | |
| Quick Ratio | 7.7 | · | 11.0 | 1.9 | 3.8 | 9.4 | · |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.1 | 0.1 | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -82.5% | 245.3% | 154.1% | -97.8% | 202.2% | · | · | |
| Revenue CAGR 3Y | 15.3% | -42.4% | -45.0% | · | · | · | · | |
| Revenue CAGR 5Y | -36.8% | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $6M | $2M | $652.0K | $30M | $10M | · | |
| Net Income TTM | $-49M | $-75M | $-87M | $-102M | $-45M | $-37M | · | |
| Market Cap | $231M | · | $337M | $97M | $360M | $2.19B | · | |
| P/E | -5.2 | -0.8 | -3.5 | -1.0 | -8.0 | -22.2 | · | |
| P/S | 231.0 | · | 203.4 | 149.5 | 12.0 | 220.4 | · | |
| P/B | 2.8 | · | 2.3 | 0.6 | 1.3 | 7.1 | · | |
| P / Tangible Book | 2.8 | 0.7 | 2.3 | 0.6 | 1.3 | 7.1 | · | |
| P / Cash Flow | -5.8 | · | -4.1 | -1.0 | -6.3 | -65.0 | · | |
| P / FCF | -5.8 | · | -4.1 | -0.9 | -5.5 | -63.7 | · | |
| Earnings Yield | -19.2% | -123.1% | -28.7% | -104.8% | -12.6% | -4.5% | · |
손익계산서 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1M | $0 | $0 | $0 | $3M | $2M | $1M | $714.0K | $686.0K | $200.0K | $57.0K | $390.0K | $212.0K | |
| R&D Expense | $12M | $11M | $9M | $8M | $9M | $10M | $15M | $16M | $19M | $16M | $15M | $24M | $18M | $17M | $22M | $19M | |
| SG&A Expense | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $7M | |
| Operating Expenses | $16M | $16M | $13M | $12M | $13M | $14M | $20M | $21M | $25M | $21M | $20M | $29M | $23M | $22M | $27M | $25M | |
| Operating Income | $-16M | $-16M | $-13M | $-11M | $-13M | $-14M | $-20M | $-18M | $-23M | $-20M | $-19M | $-29M | $-23M | $-22M | $-26M | $-25M | |
| Interest Income | $1M | $779.0K | · | · | $804.0K | $689.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-26.0K | $-1.0K | $-2M | $660.0K | $-230.0K | $-2.0K | $-4M | $1M | $1M | $2M | $-3M | $1M | $1M | $937.0K | $-727.0K | $594.0K | |
| Net Income | $-15M | $-15M | $-13M | $-10M | $-12M | $-14M | $-19M | $-17M | $-22M | $-19M | $-18M | $-28M | $-21M | $-21M | $-25M | $-25M | |
| EPS (Basic) | $-0.12 | $-0.13 | $-0.05 | $-0.14 | $-0.24 | $-0.27 | $-0.37 | $-0.33 | $-0.42 | $-0.37 | $-0.41 | $-0.65 | $-0.50 | $-0.49 | $-0.60 | $-0.58 | |
| EPS (Diluted) | $-0.12 | $-0.13 | $-0.05 | $-0.14 | $-0.24 | $-0.27 | $-0.37 | $-0.33 | $-0.42 | $-0.37 | $-0.41 | $-0.65 | $-0.50 | $-0.49 | $-0.60 | $-0.58 | |
| Shares (Basic) | 129,779,297 | 112,234,551 | -104,567,943 | 72,184,818 | 51,002,247 | 50,965,815 | -101,432,883 | 50,833,538 | 50,791,241 | 50,566,394 | -84,784,320 | 42,477,642 | 42,467,664 | 42,439,204 | -84,745,654 | 42,386,470 | |
| Shares (Diluted) | 129,779,297 | 112,234,551 | -104,567,943 | 72,184,818 | 51,002,247 | 50,965,815 | -101,432,883 | 50,833,538 | 50,791,241 | 50,566,394 | -84,784,320 | 42,477,642 | 42,467,664 | 42,439,204 | -84,745,654 | 42,386,470 | |
| EBITDA | $-16M | $-16M | · | $-11M | $-13M | $-14M | · | $-18M | $-23M | $-20M | · | $-29M | $-23M | $-22M | · | $-25M |
대차대조표 19
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $90M | $54M | $43M | $50M | $61M | $57M | $44M | $61M | $76M | $126M | $41M | $72M | $66M | $47M | $40M | |
| Prepaid Expense | $5M | $3M | $4M | $5M | $4M | $6M | $6M | $9M | $9M | $16M | $13M | $12M | $19M | $22M | $23M | $16M | |
| Current Assets | $213M | $94M | $82M | $91M | $55M | $66M | $79M | $99M | $114M | $131M | $143M | $113M | $136M | $158M | $185M | $202M | |
| PP&E (Net) | $5M | $5M | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $13M | $14M | $15M | $16M | $17M | $18M | $18M | |
| PP&E (Gross) | · | · | $23M | · | · | · | $23M | · | · | · | $23M | · | · | · | $23M | · | |
| Accum. Depreciation | · | · | $17M | · | · | · | $13M | · | · | · | $10M | · | · | · | $6M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Total Assets | $221M | $102M | $91M | $100M | $64M | $77M | $91M | $112M | $129M | $146M | $160M | $130M | $155M | $178M | $205M | $223M | |
| Accounts Payable | $4M | $1M | $2M | $1M | $475.0K | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $5M | $7M | $3M | |
| Current Liabilities | $8M | $4M | $7M | $5M | $5M | $7M | $9M | $12M | $15M | $14M | $11M | $14M | $13M | $16M | $25M | $19M | |
| Capital Leases | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | |
| Total Liabilities | $10M | $6M | $9M | $7M | $7M | $10M | $11M | $15M | $18M | $18M | $15M | $18M | $17M | $20M | $29M | $24M | |
| Common Stock | $10.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $672M | $541M | $513M | $511M | $465M | $463M | $461M | $460M | $457M | $454M | $451M | $401M | $400M | $398M | $396M | $394M | |
| Retained Earnings | $-460M | $-445M | $-431M | $-418M | $-408M | $-395M | $-382M | $-363M | $-346M | $-325M | $-306M | $-289M | $-261M | $-240M | $-219M | $-194M | |
| AOCI | $-63.0K | $0 | $6.0K | $3.0K | $1.0K | $0 | $2.0K | $52.0K | $-5.0K | $-14.0K | $4.0K | $7.0K | $-74.0K | $-339.0K | $-877.0K | $-1M | |
| Stockholders' Equity | $211M | $96M | $82M | $93M | $57M | $68M | $80M | $97M | $111M | $129M | $145M | $113M | $138M | $158M | $176M | $199M | |
| Liabilities + Equity | $221M | $102M | $91M | $100M | $64M | $77M | $91M | $112M | $129M | $146M | $160M | $130M | $155M | $178M | $205M | $223M | |
| Shares Outstanding | 100,726,022 | 75,581,787 | 63,279,843 | 63,151,789 | 47,903,215 | 47,899,240 | 47,714,708 | 47,739,708 | 47,727,269 | 47,519,219 | 47,260,108 | 42,485,485 | 42,471,335 | 42,460,258 | 42,390,586 | 42,390,586 |
현금 흐름 9
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-10M | $-13M | $-8M | $-9M | $-10M | $-12M | $-17M | $-16M | $-11M | $-16M | $-19M | $-17M | $-19M | $-26M | $-24M | $-28M | |
| CapEx | · | · | $0 | $71.0K | · | · | $0 | $42.0K | $17.0K | $0 | $17.0K | $19.0K | $296.0K | $75.0K | $693.0K | $750.0K | |
| Investing Cash Flow | $-145M | $24M | $20M | $-43M | $0 | $16M | $31M | $-821.0K | $-5M | $-33M | $56M | $-15M | $24M | $45M | $31M | $30M | |
| Stock Issued | $80M | $21M | $-5.0K | $44M | $0 | $0 | · | $0 | · | · | · | $0 | · | · | · | · | |
| Net Stock Activity | · | $21M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $128M | $26M | $134.0K | $44M | $0 | $-57.0K | $-72.0K | $23.0K | $1M | $-184.0K | $49M | $21.0K | $33.0K | $0 | $0 | $27.0K | |
| Net Change in Cash | $-27M | $36M | $12M | $-8M | $-10M | $4M | $14M | $-17M | $-15M | $-50M | $85M | $-31M | $6M | $19M | $8M | $2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-16M | · | · | · | $-27M | · | · |
수익성 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1071.6% | · | · | · | -597.9% | -1427.1% | -1797.7% | · | -4168.8% | -11373.5% | -38001.8% | · | -11900.5% | |
| Net Margin | · | · | · | -1005.6% | · | · | · | -556.4% | -1339.5% | -1659.6% | · | -4014.7% | -10673.0% | -36357.9% | · | -11620.3% | |
| EBITDA Margin | · | · | · | -1071.6% | · | · | · | -597.9% | -1427.1% | -1797.7% | · | -4168.8% | -11373.5% | -38001.8% | · | -11900.5% | |
| ROA | -10.6% | -16.5% | · | -9.5% | -12.9% | -12.3% | · | -13.8% | -15.2% | -11.4% | · | -15.6% | -10.5% | -9.2% | · | -9.2% | |
| ROE | -11.3% | -18.1% | · | -10.6% | -14.9% | -14.0% | · | -15.9% | -17.3% | -12.9% | · | -17.6% | -11.8% | -10.2% | · | -10.7% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 27.6 | 22.1 | · | 17.0 | 10.2 | 9.1 | · | 8.0 | 7.6 | 9.1 | · | 8.0 | 10.5 | 9.9 | · | 10.5 | |
| Quick Ratio | 8.2 | 21.3 | · | 8.0 | 9.5 | 8.3 | · | 3.5 | 4.0 | 5.3 | · | 2.9 | 5.5 | 4.1 | · | 2.1 |
효율성 1
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $4M | $5M | $6M | · | $6M | $4M | $2M | · | $1M | $519.0K | $319.0K | · | $2M | |
| Net Income TTM | $-52M | $-51M | · | $-53M | $-64M | $-70M | · | $-84M | $-89M | $-88M | · | $-94M | $-94M | $-97M | · | $-94M | |
| Market Cap | $699M | $486M | · | $151M | $38M | $46M | · | $167M | $184M | $425M | · | $65M | $133M | $125M | · | $114M | |
| P/E | -11.0 | -8.2 | · | -2.4 | -0.6 | -0.7 | · | -2.0 | -2.0 | -4.4 | · | -0.7 | -1.4 | -1.3 | · | -1.2 | |
| P/S | 699.0 | 486.0 | · | 37.8 | 8.2 | 8.0 | · | 26.0 | 51.0 | 206.4 | · | 55.9 | 255.3 | 391.3 | · | 52.9 | |
| P/B | 3.3 | 5.1 | · | 1.6 | 0.7 | 0.7 | · | 1.7 | 1.7 | 3.3 | · | 0.6 | 1.0 | 0.8 | · | 0.6 | |
| P / Tangible Book | 3.3 | 5.1 | · | 1.6 | 0.7 | 0.7 | · | 1.7 | 1.7 | 3.3 | · | 0.6 | 1.0 | 0.8 | · | 0.6 | |
| P / Cash Flow | · | -36.2 | · | · | · | -3.8 | · | · | · | -26.3 | · | · | · | -4.7 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -26.3 | · | · | · | -4.7 | · | · | |
| Earnings Yield | -9.1% | -12.1% | · | -41.0% | -159.1% | -146.3% | · | -50.7% | -50.3% | -22.5% | · | -146.0% | -71.2% | -78.2% | · | -82.2% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $1M | $6M | $2M | $652.0K | $30M |
| 영업이익률 % | -5150.8% | — | -5549.6% | -15848.0% | -150.8% |
| 순이익 | $-49M | $-75M | $-87M | $-102M | $-45M |
| 희석 EPS | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 11.7 | — | 12.5 | 7.4 | 11.7 |
| 당좌 비율 | 7.7 | — | 11.0 | 1.9 | 3.8 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-40M | — | $-82M | $-106M | $-65M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 113개의 제출자 · $430.5M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 47 (+22 이전 분기 대비) | 18 (+14 이전 분기 대비) | 30 (-2 이전 분기 대비) | 15 (+3 이전 분기 대비) | +24.6M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $56,367,922 | 8,122,179 | 13.09% | 주식 |
| Redmile Group, LLC | $47,830,709 | 6,892,033 | 11.11% | 주식 |
| ORBIMED ADVISORS LLC | $43,764,521 | 6,306,127 | 10.17% | 주식 |
| Prosight Management, LP | $41,347,666 | 5,957,877 | 9.61% | 주식 |
| Frazier Life Sciences Management, L.P. | $26,025,000 | 3,750,000 | 6.05% | 주식 |
| NEXTBio Capital Management LP | $25,867,795 | 3,727,348 | 6.01% | 주식 |
| Deep Track Capital, LP | $25,724,734 | 3,706,734 | 5.98% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $22,262,583 | 3,207,865 | 5.17% | 주식 |
| PINNACLE ASSOCIATES LTD | $12,987,807 | 1,871,442 | 3.02% | 주식 |
| CLARK ESTATES INC/NY | $9,925,359 | 1,430,167 | 2.31% | 주식 |
| Aberdeen Group plc | $9,756,606 | 1,405,851 | 2.27% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $9,275,944 | 1,336,256 | 2.15% | 주식 |
| Point72 Asset Management, L.P. | $8,124,880 | 1,170,732 | 1.89% | 주식 |
| 683 Capital Management, LLC | $8,031,079 | 1,157,216 | 1.87% | 주식 |
| STATE STREET CORP | $7,123,174 | 1,026,394 | 1.65% | 주식 |
| Boxer Capital Management, LLC | $6,940,000 | 1,000,000 | 1.61% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6,572,076 | 946,985 | 1.53% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $6,282,220 | 905,219 | 1.46% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $5,161,701 | 743,761 | 1.20% | 주식 |
| TD Asset Management Inc | $3,878,599 | 558,876 | 0.90% | 주식 |
| GOLDMAN SACHS GROUP INC | $3,440,491 | 495,748 | 0.80% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $3,216,100 | 463,415 | 0.75% | 주식 |
| S&G Foundation | $3,024,098 | 435,749 | 0.70% | 주식 |
| ALGERT GLOBAL LLC | $2,923,038 | 421,187 | 0.68% | 주식 |
| FMR LLC | $2,724,616 | 392,596 | 0.63% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,131,968 | 307,200 | 0.50% | 콜 옵션 |
| Connor, Clark & Lunn Investment Management Ltd. | $1,986,214 | 286,198 | 0.46% | 주식 |
| Hillsdale Investment Management Inc. | $1,828,121 | 263,418 | 0.42% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1,575,873 | 227,071 | 0.37% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,395,634 | 201,100 | 0.32% | 풋 옵션 |
| Caption Management, LLC | $1,388,000 | 200,000 | 0.32% | 콜 옵션 |
| MILLENNIUM MANAGEMENT LLC | $1,346,416 | 194,008 | 0.31% | 주식 |
| West Tower Group, LLC | $1,329,878 | 191,625 | 0.31% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,317,899 | 189,899 | 0.31% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $1,290,472 | 185,947 | 0.30% | 주식 |
| TAKEDA PHARMACEUTICAL CO LTD | $1,232,329 | 515,619 | 0.29% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $863,829 | 124,471 | 0.20% | 주식 |
| XTX Topco Ltd | $650,653 | 93,754 | 0.15% | 주식 |
| TWO SIGMA ADVISERS, LP | $622,690 | 170,600 | 0.14% | 주식 |
| Jump Financial, LLC | $616,272 | 88,800 | 0.14% | 주식 |
| SPHERA FUNDS MANAGEMENT LTD. | $600,039 | 86,461 | 0.14% | 주식 |
| Bank of New York Mellon Corp | $588,373 | 84,780 | 0.14% | 주식 |
| Nuveen, LLC | $565,069 | 81,422 | 0.13% | 주식 |
| Pathstone Holdings, LLC | $513,255 | 73,956 | 0.12% | 주식 |
| Squarepoint Ops LLC | $496,536 | 71,547 | 0.12% | 주식 |
| RHUMBLINE ADVISERS | $496,120 | 71,488 | 0.12% | 주식 |
| Coastline Trust Co | $485,800 | 70,000 | 0.11% | 주식 |
| BlackRock, Inc. | $447,602 | 64,496 | 0.10% | 주식 |
| UBS Group AG | $397,239 | 57,239 | 0.09% | 주식 |
| Verdad Advisers, LP | $397,183 | 57,231 | 0.09% | 주식 |
| WELLS FARGO & COMPANY/MN | $384,247 | 55,367 | 0.09% | 주식 |
| BLAIR WILLIAM & CO/IL | $378,029 | 54,471 | 0.09% | 주식 |
| Cerity Partners LLC | $366,050 | 52,745 | 0.09% | 주식 |
| Davis Asset Management, L.P. | $335,035 | 48,276 | 0.08% | 주식 |
| BANK OF AMERICA CORP /DE/ | $318,671 | 45,918 | 0.07% | 주식 |
| HSBC HOLDINGS PLC | $311,759 | 42,445 | 0.07% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $293,562 | 42,300 | 0.07% | 주식 |
| MetLife Investment Management, LLC | $259,695 | 37,420 | 0.06% | 주식 |
| JANE STREET GROUP, LLC | $226,244 | 32,600 | 0.05% | 콜 옵션 |
| AMERIPRISE FINANCIAL INC | $218,950 | 31,549 | 0.05% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $213,412 | 33,190 | 0.05% | 주식 |
| CITADEL ADVISORS LLC | $208,894 | 30,100 | 0.05% | 콜 옵션 |
| MIDDLETON & CO INC/MA | $208,200 | 30,000 | 0.05% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $195,201 | 28,127 | 0.05% | 주식 |
| EntryPoint Capital, LLC | $183,126 | 26,387 | 0.04% | 주식 |
| RITHOLTZ WEALTH MANAGEMENT | $180,440 | 26,000 | 0.04% | 주식 |
| CITIGROUP INC | $175,103 | 25,231 | 0.04% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $174,721 | 25,176 | 0.04% | 주식 |
| JPMORGAN CHASE & CO | $174,196 | 25,430 | 0.04% | 주식 |
| Invesco Ltd. | $169,766 | 24,462 | 0.04% | 주식 |
| Mallini Complete Financial Planning LLC | $157,066 | 22,632 | 0.04% | 주식 |
| State of Wyoming | $151,188 | 21,785 | 0.04% | 주식 |
| CHOREO, LLC | $139,849 | 27,251 | 0.03% | 주식 |
| MGO ONE SEVEN LLC | $138,800 | 20,000 | 0.03% | 주식 |
| Vanguard Global Advisers, LLC | $137,655 | 19,835 | 0.03% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $125,558 | 18,092 | 0.03% | 주식 |
| BENJAMIN EDWARDS INC | $119,992 | 17,290 | 0.03% | 주식 |
| China Universal Asset Management Co., Ltd. | $101,609 | 14,641 | 0.02% | 주식 |
| JANE STREET GROUP, LLC | $100,630 | 14,500 | 0.02% | 풋 옵션 |
| NEW YORK STATE COMMON RETIREMENT FUND | $98,548 | 14,200 | 0.02% | 주식 |
| VANGUARD GROUP INC | $95,977 | 26,295 | 0.02% | 주식 |
| T. Rowe Price Investment Management, Inc. | $93,222 | 13,432,540 | 0.02% | 주식 |
| Creative Planning | $85,605 | 12,335 | 0.02% | 주식 |
| FOX RUN MANAGEMENT, L.L.C. | $83,523 | 12,035 | 0.02% | 주식 |
| VOYA INVESTMENT MANAGEMENT LLC | $81,739 | 11,778 | 0.02% | 주식 |
| BARCLAYS PLC | $76,055 | 10,959 | 0.02% | 주식 |
| INTECH INVESTMENT MANAGEMENT LLC | $73,522 | 10,594 | 0.02% | 주식 |
| NORTHERN TRUST CORP | $66,735 | 9,616 | 0.02% | 주식 |
| Nuveen Asset Management, LLC | $64,176 | 53,038 | 0.01% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $63,966 | 9,217 | 0.01% | 주식 |
| Legal & General Group Plc | $41,335 | 5,956 | 0.01% | 주식 |
| Ameritas Investment Partners, Inc. | $38,635 | 5,567 | 0.01% | 주식 |
| SIMPLEX TRADING, LLC | $37,593 | 5,417 | 0.01% | 주식 |
| Tower Research Capital LLC (TRC) | $35,623 | 5,133 | 0.01% | 주식 |
| Point72 Asia (Singapore) Pte. Ltd. | $34,545 | 14,454 | 0.01% | 주식 |
| Russell Investments Group, Ltd. | $33,985 | 4,897 | 0.01% | 주식 |
| Cubist Systematic Strategies, LLC | $21,183 | 8,863 | 0.00% | 주식 |
| PRICE T ROWE ASSOCIATES INC /MD/ | $17,980 | 2,590,711 | 0.00% | 주식 |
| ROYAL BANK OF CANADA | $14,000 | 1,995 | 0.00% | 주식 |
| DEUTSCHE BANK AG\ | $7,100 | 1,023 | 0.00% | 주식 |
회사 내부자 18 명의 내부자 · 7 임원 · 12 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Taylor Schreiber | Chief Executive Officer | 2026년 5월 12일 M | 122,222 | 0 | 0 | $0 |
| Andrew R Neill | Chief Financial Officer | 2026년 5월 12일 M | 292,251 | 0 | 0 | $0 |
| Abhinav A. Shukla | Chief Technical Officer | 2026년 7월 6일 M | 98,533 | 0 | 4 | $-183,249 |
| Arundathy N. Pandite | Chief Medical Officer | 2026년 6월 30일 S | 136,219 | 0 | 2 | $-408,600 |
| Stephen Stout | General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer | 2026년 5월 15일 M | 93,366 | 0 | 0 | $0 |
| Casi Deyoung | Chief Business Officer | 2026년 1월 25일 F | 73,480 | 0 | 0 | $0 |
| Erin Ator Thomson | General Counsel | 2023년 1월 25일 A | 103,209 | 0 | 0 | $0 |
| Mona Ashiya | 이사 | 2026년 6월 11일 P | 1,051,021 | 2 | 0 | $5,486,330 |
| Clay B Siegall | 이사 | 2026년 6월 9일 P | 318,608 | 1 | 0 | $250,000 |
| Daniel G. Baker | 이사 | 2026년 5월 29일 A | — | 0 | 0 | $0 |
| Helen M Boudreau | 이사 | 2026년 5월 29일 A | — | 0 | 0 | $0 |
| George Golumbeski | 이사 | 2026년 5월 29일 A | 54,613 | 0 | 0 | $0 |
| Neil W Gibson | 이사 | 2026년 5월 29일 A | — | 0 | 0 | $0 |
| Amy Kate Sasser | 이사 | 2025년 7월 14일 A | — | 0 | 0 | $0 |
| Carrie Brownstein | 이사 | 2025년 7월 14일 A | — | 0 | 0 | $0 |
| Tyler Brous | 이사 | 2025년 7월 14일 A | 238,088 | 0 | 0 | $0 |
| Michael Stewart Lee | 이사 | 2025년 7월 14일 A | — | 0 | 0 | $0 |
| Josiah Hornblower | 이사 | 2021년 7월 15일 S | 2,966,709 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 4 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Redmile Group, LLC, Jeremy C. Green, Redmile Biopharma Investments II, L.P. ×7 제출 서류 | 2026년 7월 17일 | 9.90% | 수정본 | — | SEC |
| ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC, OrbiMed Genesis GP LLC ×2 제출 서류 | 2026년 6월 15일 | 9.99% | 수정본 | — | SEC |
| JOSIAH HORNBLOWER ×2 제출 서류 | 2022년 12월 9일 | — | 최초 제출 | 수동적 투자 | SEC |
| Taylor Schreiber, M.D., Ph.D. | 2020년 10월 23일 | — | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 15 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 48,485 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 49,623 NS | 2026년 4월 30일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 2,719 NS | 2026년 4월 30일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| IWN · iShares Trust | — | — | 2026년 8월 17일 | 일간 |
| IWO · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWM · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWC · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026년 7월 13일 | 일간 |
| VHT · VANGUARD WORLD FUND | — | — | 2026년 7월 20일 | 일간 |